The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2020

Filed:

Jul. 14, 2016
Applicant:

Personal Genome Diagnostics Inc., Baltimore, MD (US);

Inventors:

Victor Velculescu, Baltimore, MD (US);

Theresa Zhang, Baltimore, MD (US);

James Robert White, Baltimore, MD (US);

Luis Diaz, Ellicot City, MD (US);

Assignee:

Personal Genome Diagnostics Inc., Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); G01N 33/574 (2006.01); G16B 20/00 (2019.01); G16B 35/00 (2019.01); G16C 20/60 (2019.01); G16H 10/40 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); G01N 33/574 (2013.01); G16B 20/00 (2019.02); G16B 35/00 (2019.02); G16C 20/60 (2019.02); G16H 10/40 (2018.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01); G01N 2333/70539 (2013.01);
Abstract

Cancer immunology provides promising new avenues for cancer treatment but validation of potential neoantigens to target is costly and expensive. Analysis of MHC binding affinity, antigen processing, similarity to known antigens, predicted expression levels (as mRNA or proteins), self-similarity, and mutant allele frequency, provides screening method to identify and prioritize candidate neoantigens using sequencing data. Methods of the invention thereby save time and money by identifying the priority candidate neoantigens for further experimental validation.


Find Patent Forward Citations

Loading…